186 related articles for article (PubMed ID: 28119475)
21. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.
Xu C; Wang A; Marin M; Honnen W; Ramasamy S; Porter E; Subbian S; Pinter A; Melikyan GB; Lu W; Chang TL
Viruses; 2021 Jun; 13(7):. PubMed ID: 34206990
[TBL] [Abstract][Full Text] [Related]
22. The Function and Modification of Human Defensin 5.
Chang XY; Zhang MW; Zhang LJ; Chai LQ
Protein Pept Lett; 2023; 30(10):830-840. PubMed ID: 37861034
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of adenovirus neutralization by Human alpha-defensins.
Smith JG; Nemerow GR
Cell Host Microbe; 2008 Jan; 3(1):11-9. PubMed ID: 18191790
[TBL] [Abstract][Full Text] [Related]
24. Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.
Dugan AS; Maginnis MS; Jordan JA; Gasparovic ML; Manley K; Page R; Williams G; Porter E; O'Hara BA; Atwood WJ
J Biol Chem; 2008 Nov; 283(45):31125-32. PubMed ID: 18782756
[TBL] [Abstract][Full Text] [Related]
25. The cellular endosomal protein stannin inhibits intracellular trafficking of human papillomavirus during virus entry.
Lipovsky A; Erden A; Kanaya E; Zhang W; Crite M; Bradfield C; MacMicking J; DiMaio D; Schoggins JW; Iwasaki A
J Gen Virol; 2017 Nov; 98(11):2821-2836. PubMed ID: 29058661
[TBL] [Abstract][Full Text] [Related]
26. Human alpha-defensins block papillomavirus infection.
Buck CB; Day PM; Thompson CD; Lubkowski J; Lu W; Lowy DR; Schiller JT
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1516-21. PubMed ID: 16432216
[TBL] [Abstract][Full Text] [Related]
27. Topography of the Human Papillomavirus Minor Capsid Protein L2 during Vesicular Trafficking of Infectious Entry.
DiGiuseppe S; Keiffer TR; Bienkowska-Haba M; Luszczek W; Guion LG; Müller M; Sapp M
J Virol; 2015 Oct; 89(20):10442-52. PubMed ID: 26246568
[TBL] [Abstract][Full Text] [Related]
28. Vesicular trafficking of incoming human papillomavirus 16 to the Golgi apparatus and endoplasmic reticulum requires γ-secretase activity.
Zhang W; Kazakov T; Popa A; DiMaio D
mBio; 2014 Sep; 5(5):e01777-14. PubMed ID: 25227470
[TBL] [Abstract][Full Text] [Related]
29. A Dual Role for the Nonreceptor Tyrosine Kinase Pyk2 during the Intracellular Trafficking of Human Papillomavirus 16.
Gottschalk EY; Meneses PI
J Virol; 2015 Sep; 89(17):9103-14. PubMed ID: 26109718
[TBL] [Abstract][Full Text] [Related]
30. Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection.
Hazrati E; Galen B; Lu W; Wang W; Ouyang Y; Keller MJ; Lehrer RI; Herold BC
J Immunol; 2006 Dec; 177(12):8658-66. PubMed ID: 17142766
[TBL] [Abstract][Full Text] [Related]
31. Elucidating the Bacterial Membrane Disruption Mechanism of Human α-Defensin 5: A Theoretical Study.
Jung SW; Lee J; Cho AE
J Phys Chem B; 2017 Feb; 121(4):741-748. PubMed ID: 28067516
[TBL] [Abstract][Full Text] [Related]
32. Integrin and defensin modulate the mechanical properties of adenovirus.
Snijder J; Reddy VS; May ER; Roos WH; Nemerow GR; Wuite GJ
J Virol; 2013 Mar; 87(5):2756-66. PubMed ID: 23269786
[TBL] [Abstract][Full Text] [Related]
33. Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment.
Rapista A; Ding J; Benito B; Lo YT; Neiditch MB; Lu W; Chang TL
Retrovirology; 2011 Jun; 8():45. PubMed ID: 21672195
[TBL] [Abstract][Full Text] [Related]
34. Alpha-defensin 5 differentially modulates adenovirus vaccine vectors from different serotypes in vivo.
Tartaglia LJ; Badamchi-Zadeh A; Abbink P; Blass E; Aid M; Gebre MS; Li Z; Pastores KC; Trott S; Gupte S; Larocca RA; Barouch DH
PLoS Pathog; 2019 Dec; 15(12):e1008180. PubMed ID: 31841560
[TBL] [Abstract][Full Text] [Related]
35. Alpha-defensin binding expands human adenovirus tropism.
Zhao C; Porter JM; Burke PC; Arnberg N; Smith JG
bioRxiv; 2024 May; ():. PubMed ID: 38854108
[TBL] [Abstract][Full Text] [Related]
36. Human Papillomavirus 16 Infection Induces VAP-Dependent Endosomal Tubulation.
Siddiqa A; Massimi P; Pim D; Broniarczyk J; Banks L
J Virol; 2018 Mar; 92(6):. PubMed ID: 29321327
[TBL] [Abstract][Full Text] [Related]
37. The adsorption of human defensin 5 on bacterial membranes: simulation studies.
Awang T; Pongprayoon P
J Mol Model; 2018 Sep; 24(10):273. PubMed ID: 30187138
[TBL] [Abstract][Full Text] [Related]
38. Anti-HIV activity of human defensin 5 in primary CD4+ T cells under serum-deprived conditions is a consequence of defensin-mediated cytotoxicity.
Ding J; Tasker C; Valere K; Sihvonen T; Descalzi-Montoya DB; Lu W; Chang TL
PLoS One; 2013; 8(9):e76038. PubMed ID: 24086683
[TBL] [Abstract][Full Text] [Related]
39. Different dynamics and pathway of disulfide bonds reduction of two human defensins, a molecular dynamics simulation study.
Zhang L
Proteins; 2017 Apr; 85(4):665-681. PubMed ID: 28106297
[TBL] [Abstract][Full Text] [Related]
40. Paneth cell trypsin is the processing enzyme for human defensin-5.
Ghosh D; Porter E; Shen B; Lee SK; Wilk D; Drazba J; Yadav SP; Crabb JW; Ganz T; Bevins CL
Nat Immunol; 2002 Jun; 3(6):583-90. PubMed ID: 12021776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
